Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin.
about
High prevalence of blaCTX-M-1/IncI1/ST3 and blaCMY-2/IncI1/ST2 plasmids in healthy urban dogs in France.ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance.Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in DenmarkMultidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons.Public health risk of antimicrobial resistance transfer from companion animals.Third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates from humans and companion animals in Switzerland: spread of a DHA-producing sequence type 11 clone in a veterinary setting.CTX-M-1 and CTX-M-15-producing Escherichia coli in dog faeces from public gardens.Selection of broad-spectrum cephalosporin-resistant Escherichia coli in the feces of healthy dogs after administration of first-generation cephalosporins.Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis.High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs.Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coliHigh diversity of plasmids harbouring blaCMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA.Raw pet food as a risk factor for shedding of extended-spectrum beta-lactamase-producing Enterobacteriaceae in household cats.Risk factors for faecal colonisation with Escherichia coli producing extended-spectrum and plasmid-mediated AmpC β-lactamases in dogsTranscriptome analysis of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus exposed to cefotaxime
P2860
Q34057319-3E656C72-C117-4E69-9CE8-C38EF2774415Q36975171-234012AB-5568-43E7-B662-65C7C3B692F5Q37173645-8DEBDDF8-1A69-4653-8499-AAAD4599F8C8Q38556197-4A106549-445A-47A8-AF2C-AD41E51701C6Q38780024-1936BA95-1698-4F6C-98BF-3D76655DF632Q39566338-FA1EEB75-D499-423F-B013-E44302A9EA47Q40273321-05DCE222-8509-44DE-B386-6106FEE7394BQ40362326-75E782BD-DF02-4C1A-90E8-0246167C815EQ40423406-C3E6B2C9-9AE6-46E5-9A65-4145A2DF8405Q42019900-581F658F-1DDB-4498-8FD3-3809815BB9ACQ42219799-D90328F1-6E0B-480B-B666-64A9F199F4B8Q42319609-526EB8C9-57FE-44E0-B7CE-88267A094C19Q46818348-5F7D3CCA-8312-4E96-AB3C-EAEFCAA8C8F2Q47109438-2021BFA5-BF43-401A-9B1F-1935CA2C910FQ57729521-8C338677-7B6C-4E13-8A92-040D1D2A582EQ58099109-915AF205-2A8A-46CC-9B14-957AE20B968D
P2860
Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@en
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@nl
type
label
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@en
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@nl
prefLabel
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@en
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@nl
P50
P1476
Selection of CMY-2 producing E ...... dogs treated with cephalexin.
@en
P2093
Ingrid B Gaustad
P304
P356
10.1016/J.VETMIC.2011.03.015
P577
2011-03-21T00:00:00Z